<DOC>
	<DOCNO>NCT00785733</DOCNO>
	<brief_summary>The primary objective non-interventional study evaluate efficacy SymbicortÂ® SMART treatment adult patient moderate severe asthma use ACQ score 6 month period</brief_summary>
	<brief_title>NIS-observe Treatment Efficacy Maintaining Symptoms Control Moderate/Severe Asthma With Symbicort SMART</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<criteria>patient eligible entry study patient diagnose moderate severe asthma , doctor already decide treat Symbicort SMART within last month , inclusion program All eligible patient include protocol provide receive detailed information advance sign consent grant access data collect programme . All patient know hypersensitivity Symbicort excipients include study . As per valid Romanian SmPC , concomitant medication , could result drug interaction could jeopardise patient safety carefully consider patient enrol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>asthma</keyword>
</DOC>